Holen Sie sich die Stockscreener-App
0.3378
1.23%
-0.0042
Handel nachbörslich:
.35
0.0122
+3.61%
Schlusskurs vom Vortag:
$0.342
Offen:
$0.36
24-Stunden-Volumen:
78,089
Relative Volume:
0.14
Marktkapitalisierung:
$7.44M
Einnahmen:
$275.60K
Nettoeinkommen (Verlust:
$-8.33M
KGV:
-0.7313
EPS:
-0.4619
Netto-Cashflow:
$-5.40M
1W Leistung:
-29.80%
1M Leistung:
+2.36%
6M Leistung:
-40.74%
1J Leistung:
-66.22%
1-Tages-Spanne:
$0.3337
$0.373
1-Wochen-Bereich:
$0.3209
$0.4954
52-Wochen-Spanne:
$0.305
$2.00
Nexalin Technology Inc Stock (NXL) Company Profile
Firmenname
Nexalin Technology Inc
Sektor
Branche
Telefon
(832) 260-0222
Adresse
1776 YORKTOWN, HOUSTON
Compare NXL vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NXL
Nexalin Technology Inc
|
0.3378 | 9.73M | 275.60K | -8.33M | -5.40M | -0.4619 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Nexalin Technology Inc Aktie (NXL) Neueste Nachrichten
Nexalin Technology Inc (NXL) Institutional Confidence - TradingKey
Nexalin Appeals Nasdaq Delisting Following Compliance Shortfalls - TipRanks
Nexalin Technology Received Notice of Delisting - TradingView
Nexalin Technology Inc (NXL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
NXL|Nexalin Technology Inc|Price:0.483|Chg%:+0.002 - TradingKey
Nexalin Technology Inc (NXL) Cash Flow - TradingKey
Nexalin Technology Inc (NXL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NXL|Nexalin Technology Inc|Price:0.500|Chg%:+0.019 - TradingKey
Nexalin Technology Inc (NXL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nexalin Technology Inc (NXL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nexalin Technology Inc (NXL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
NXL|Nexalin Technology Inc|Price:0.481|Chg%:+0.013 - TradingKey
Nexalin Technology, Inc. Revenue Breakdown – NASDAQ:NXL - TradingView
Nexalin Technology Inc (NXL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Nexalin Technology (NXL) Registration filing Summary - Quartr
Nexalin Technology Inc. (NXL) Q1 2026 Earnings: EPS Misses Estimates Amid Pre-Revenue Development StageProfitability Analysis - dars.gov.et
Nexalin Technology (NXL) Surges Over 11% as Shares Test Key Resistance LevelATR Stop - dars.gov.et
NXL | Nexalin Technology, Inc. Common Executive Compensation - Quiver Quantitative
Nexalin Technology | ARS: Annual Report to Security Holders - Moomoo
Form DEF 14A Nexalin Technology Inc For: 10 July By Investing.com - Investing.com Nigeria
Nexalin Technology (NXL) plans new 7M-share incentive pool and reverse split authority - Stock Titan
Nexalin Technology (NXL) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Stage ContinuesFinal Results - DonanımHaber
Enterprise value to revenue forward of Nexalin Technology, Inc. – NASDAQ:NXL - TradingView
Price to book forward of Nexalin Technology, Inc. – NASDAQ:NXL - TradingView
Price to sales forward of Nexalin Technology, Inc. – NASDAQ:NXL - TradingView
Price to earnings forward of Nexalin Technology, Inc. – NASDAQ:NXL - TradingView
NXL Q1 2026 Earnings: EPS Misses Estimates, Stock Declines 5%Margin Compression Risk - dars.gov.et
Form PRE 14A Nexalin Technology Inc For: 29 June By Investing.com - Investing.com South Africa
Nexalin Technology (NXL) seeks shareholder votes for equity plan, reverse split - Stock Titan
NexaLine Technology Registers 1.2 Million Shares for Resale - Moomoo
Nexalin Technology | PRE 14A: Preliminary proxy statements relating to merger or acquisition - Moomoo
Nexalin Technology Secures US Patent for Deep-Brain Stimulation Targeting Insomnia - Sleep Review
Nexalin Technology Inc. (NXL) Q1 2026 Earnings: EPS Miss Amid Pre-Revenue Stage, Stock Rises 4%Profit Guidance Range - dars.gov.et
Nexalin Technology, Inc. Actuals & Estimates (NASDAQ:NXL) - TradingView
$Nexalin Technology (NXL.US)$ - Moomoo
Nexalin Technology Inc (NXLIW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
NXL Forecast — Price Target — Prediction for 2027 - TradingView
NXL Stock Price, Quote & Chart - ChartMill
Nexalin Technology Announces that the Investigator of Its - GlobeNewswire
Nexalin's Brazilian clinical trial investigator wins award for insomnia treatment research using DIFS™ platform - Pluang
Nexalin Technology Inc (NXL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Exclusive: Nexalin Brazil trial shows benefits across anxiety, sleep and quality of life - MSN
Nexalin Technology (NXL) Continues Slide, Approaches Critical Support at $0.35Volume Weighted Price - DonanımHaber
Nexalin Technology, Inc. Financial Disclosures & SEC Filings - TradingView
NXL Q1 2026 Earnings: Wider-than-Expected Loss Pressures SharesShare Repurchase Impact - dars.gov.et
Nexalin Technology Inc (NXL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Nexalin Technology Inc (NXLIW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Nexalin Technology Inc (NXLIW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Nexalin Technology Inc (NXLIW) Institutional Confidence - TradingKey
Nexalin Technology Inc (NXLIW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Nexalin Technology Adopts Second Amended and Restated Bylaws Effective June 16, 2026 - Minichart
Finanzdaten der Nexalin Technology Inc-Aktie (NXL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.04%
11.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):